[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"glucose-metabolism-disorders-in-cystic-fibrosis\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:glucose-metabolism-disorders-in-cystic-fibrosis":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":23,"briefSummary":25,"conditions":26,"keywords":28,"overallStatus":32,"whyStopped":4,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":41,"locationsCount":5},"100658398","reproducibility-of-continuous-glucose-monitoring-cgm-in-the-assessment-of-glucose-metabolism-disorders-in-children-with-cystic-fibrosis-100658398",false,"NCT07851831","Reproducibility of Continuous Glucose Monitoring (CGM) in the Assessment of Glucose Metabolism Disorders in Children With Cystic Fibrosis","CGMUCODIAB","Inclusion Criteria:\n\n* Patients aged 10 to 17 years\n* Diagnosed with cystic fibrosis (CF)\n* Managed by the pediatric CF care center (CRCM) of the Groupement Hospitalier Est\n* Patients presenting with one of the following three stages are included: normal glucose tolerance with or without indeterminate glucose tolerance (INDET), impaired fasting glucose (IFG), and impaired glucose tolerance (IGT)\n\nExclusion Criteria:\n\n* Patients with treated or untreated diabetes\n* Patients presenting with a pulmonary exacerbation and currently receiving antibiotic therapy\n* Patients participating in another clinical trial that could interfere, in the investigator's judgment, with the study findings\n* Refusal of the patient and\u002For the legal guardian(s) to participate in the study\n* Pregnant, parturient, or breastfeeding women\n* Persons deprived of liberty by a judicial or administrative decision\n* Persons undergoing psychiatric care\n* Persons admitted to a healthcare or social institution for purposes other than research\n* Persons not affiliated with a social security scheme or beneficiaries of a similar scheme","ALL","10 Years","17 Years",{"count":20,"type":21},30,"ESTIMATED","INTERVENTIONAL",[24],"NA","Glucose metabolism disorders in cystic fibrosis (CF-GMD) are common and have a negative clinical impact. Screening currently relies on the oral glucose tolerance test (OGTT); however, this procedure is burdensome and complex for both patients and healthcare providers. Continuous glucose monitoring (CGM) is increasingly used in CF centers for CF-GMD screening, either alone or alongside the OGTT. While long-term (one-year) OGTT reproducibility is known to be poor, the short- and medium-term reproducibility of CGM remains unknown. This examination is poised to become a major tool in CF-GMD investigation, upon which critical therapeutic decisions could be based. The primary objective of this project is to evaluate the short-term variability of CGM data.",[27],"Glucose Metabolism Disorders in Cystic Fibrosis",[29,30,31],"Cystic Fibrosis","Glucose metabolism disorders","Continuous Glucose Monitoring","NOT_YET_RECRUITING","2026-09-25",{"date":35,"type":36},"2026-10-01","ACTUAL",{"date":38,"type":21},"2026-11",{"date":40,"type":21},"2028-05",{"name":42,"class":43},"Hospices Civils de Lyon","OTHER"]